TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9298778

Group type: EXPERIMENTAL
Intervention: Creatine supplementation (20 g daily for 5 days)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 8509527

Group type: EXPERIMENTAL
Intervention: ECT twice a week
Number of subjects: 30

Group type: COMPARATOR
Intervention: ECT thrice a week
Number of subjects: 30
Study: 3434161

Group type: EXPERIMENTAL
Intervention: Midazolam 0.05 mg/kg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Diazepam 0.15 mg/kg
Number of subjects: 8
Study: 28562133

Group type: EXPERIMENTAL
Intervention: Dietary nitrate (NO3‐) supplementation (beetroot juice)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 27077574

Group type: EXPERIMENTAL
Intervention: Functional electrical stimulation cycling
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control group (no exercise intervention)
Number of subjects: 11
Study: 25772212

Group type: EXPERIMENTAL
Intervention: MamaNatalie (MG) - 45 minutes of SVD simulation using an obstetrical abdominal-pelvic model
Number of subjects: 110

Group type: COMPARATOR
Intervention: Noelle (NG) - 45 minutes of SVD simulation using a high-fidelity, computer-controlled mannequin
Number of subjects: 110
Study: 23507132

Group type: EXPERIMENTAL
Intervention: Open ultra‐rapid vitrification (10%/10% and 20%/20% ethylene glycol/dimethylsulphoxide)
Number of subjects: 432

Group type: COMPARATOR
Intervention: Closed aseptic vitrification (5%/5% ethylene glycol/dimethylsulphoxide)
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: Open ultra‐rapid vitrification
Number of subjects: 432

Group type: COMPARATOR
Intervention: Closed aseptic vitrification
Number of subjects: 432
Study: 21090893

Group type: EXPERIMENTAL
Intervention: Tailored intervention
Number of subjects: 443

Group type: COMPARATOR
Intervention: Generic intervention
Number of subjects: 443
Study: 18410326

Group type: EXPERIMENTAL
Intervention: Oral extended-release oxybutynin 5 mg once daily
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 16368813

Group type: EXPERIMENTAL
Intervention: Frakefamide (FF) 1.22 mg/kg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Morphine (M-large) 0.44 mg/kg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Morphine (M-small) 0.11 mg/kg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (Sodium chloride 9 mg/mL)
Number of subjects: 12
Study: 12784317

Group type: EXPERIMENTAL
Intervention: Simvast (Julphar, UAE)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Zocor (MSD, Netherlands)
Number of subjects: 24
Study: 10836778

Group type: EXPERIMENTAL
Intervention: Automated blood pressure machines
Number of subjects: 3
Study: 8975955

Group type: EXPERIMENTAL
Intervention: Fiber supplement (Plantago Ovata)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 8384054

Group type: EXPERIMENTAL
Intervention: Epidural anesthesia
Number of subjects: 47

Group type: COMPARATOR
Intervention: Spinal anesthesia
Number of subjects: 47
Study: 3100309

Group type: EXPERIMENTAL
Intervention: Ciclosporin and prednisone
Number of subjects: 40

Group type: COMPARATOR
Intervention: Prednisone
Number of subjects: 40
Study: 30086434

Group type: EXPERIMENTAL
Intervention: Medical marijuana use
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: Non-medical marijuana use
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: Non-medical marijuana use over time
Number of subjects: 307

Group type: COMPARATOR
Intervention: No marijuana use
Number of subjects: 307
Study: 27776764

Group type: EXPERIMENTAL
Intervention: Manual Acupuncture
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Electromagnetic Field Stimulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Laser Acupuncture
Number of subjects: 0
Study: 24849104

Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 2198

Group type: COMPARATOR
Intervention: Heparins with routine GPI
Number of subjects: 2198

Group type: COMPARATOR
Intervention: Heparins only with bailout GPI
Number of subjects: 2198
Study: 22236796

Group type: EXPERIMENTAL
Intervention: onaBoNTA (200 IU injected into the bladder wall)
Number of subjects: 240
Study: 20690893

Group type: EXPERIMENTAL
Intervention: Solifenacin 5 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oxybutynin immediate-release 15 mg/day
Number of subjects: 0
Study: 18759956

Group type: EXPERIMENTAL
Intervention: Fish-based energy-restricted diet
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 32
Study: 15948985

Group type: EXPERIMENTAL
Intervention: Pimecrolimus 10 mg b.d.
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Pimecrolimus 20 mg b.d.
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Pimecrolimus 30 mg b.d.
Number of subjects: 143

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 143
Study: 12563622

Group type: EXPERIMENTAL
Intervention: Dark chocolate (94 mg Ox + 26 mg Ca)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Milk chocolate (94 mg Ox + 430 mg Ca)
Number of subjects: 70
Study: 10546919

Group type: EXPERIMENTAL
Intervention: Grapefruit juice (8-ounce glass)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Water
Number of subjects: 16
Study: 8904579

Group type: EXPERIMENTAL
Intervention: 100% O2 breathing for 10 min
Number of subjects: 16

Group type: COMPARATOR
Intervention: Room air breathing for 10 min
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 100% O2 breathing
Number of subjects: 16
Study: 1846787

Group type: EXPERIMENTAL
Intervention: Insulin infusion at 6, 35, 200 or 1200 m-units min-1 m-2 for 2 hours
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Insulin infusion at higher rates
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 24
Study: 6439144

Group type: EXPERIMENTAL
Intervention: Group A (rudimentary infarction)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Group B (subendocardial infarct)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Group C (inferior wall infarcts)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Group D (transmural anterior infarcts)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: All patients (treated medically)
Number of subjects: 80
Study: 31651531

Group type: EXPERIMENTAL
Intervention: Hydrocortisone
Number of subjects: 1950

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1950
Study: 29500678

Group type: EXPERIMENTAL
Intervention: Text message support (daily text message for 1 year)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 95
Study: 26488759

Group type: EXPERIMENTAL
Intervention: Hypnotic induction
Number of subjects: 121

Group type: COMPARATOR
Intervention: Listening to music (control condition)
Number of subjects: 121
Study: 24790271

Group type: EXPERIMENTAL
Intervention: Adaptive servoventilation (ASV)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Continuous positive airway pressure (CPAP)
Number of subjects: 66
Study: 22326210

Group type: EXPERIMENTAL
Intervention: Buffered hypertonic saline (BHS)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Normal saline (NSS)
Number of subjects: 81
Study: 20303287

Group type: COMPARATOR
Intervention: Single-row repair
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Double-row repair
Number of subjects: 68
Study: 18557842

Group type: EXPERIMENTAL
Intervention: Iowa Strengthening Families Program (ISFP)
Number of subjects: 2127

Group type: EXPERIMENTAL
Intervention: Life Skills Training (LST) plus revised ISFP (SFP 10-14)
Number of subjects: 2127

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 2127
Study: 15942495

Group type: EXPERIMENTAL
Intervention: Local Anesthesia (LA)
Number of subjects: 480

Group type: COMPARATOR
Intervention: General Anesthesia (GA)
Number of subjects: 480
Study: 11794433

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 220

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 220
Study: 10422654

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 60

Group type: COMPARATOR
Intervention: TENS
Number of subjects: 60
Study: 8583793

Group type: EXPERIMENTAL
Intervention: TCV-116 2.5 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TCV-116 5 mg
Number of subjects: 0
Study: 2125013

Group type: EXPERIMENTAL
Intervention: Ponalrestat
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 6277642

Group type: EXPERIMENTAL
Intervention: ORG 2766 (5 mg i.m.)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: ORG 2766 (20 mg i.m.)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: TRH (10 micrograms/kg i.v.)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Peptides with non-alcoholic drink
Number of subjects: 16

Group type: COMPARATOR
Intervention: Alcohol (1.5 g/kg)
Number of subjects: 16
Study: 30251205

Group type: EXPERIMENTAL
Intervention: ASXL2 mutations
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: ZBTB7A mutations
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Cohesin complex gene mutations
Number of subjects: 41
Study: 28486721

Group type: EXPERIMENTAL
Intervention: Topography-guided LASIK
Number of subjects: 22

Group type: COMPARATOR
Intervention: SMILE
Number of subjects: 22
Study: 26113580

Group type: EXPERIMENTAL
Intervention: Doxorubicin, cyclophosphamide, and paclitaxel, dosed by actual body weight
Number of subjects: 1909
Study: 23538148

Group type: EXPERIMENTAL
Intervention: Online training (OLT)
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: OLT plus motivational enhancement (ME)
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: OLT+ME plus a learning community
Number of subjects: 181
Study: 21345942

Group type: EXPERIMENTAL
Intervention: Adenosine infusion
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Candesartan (32 mg/day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: COMPARATOR
Intervention: Nitroprusside (vasodilator control)
Number of subjects: 12
Study: 19969220

Group type: EXPERIMENTAL
Intervention: Aspheric silicone monofocal IOL (MS 612 ASP‐Y) implanted in the capsular bag followed by sulcus placement of an add‐on multifocal IOL (MS 714 PB) with a +3.50 D diffractive element.
Number of subjects: 30
Study: 16982107

Group type: EXPERIMENTAL
Intervention: Lifestyle modification (LSM)
Number of subjects: 502

Group type: EXPERIMENTAL
Intervention: Metformin (Met)
Number of subjects: 502

Group type: EXPERIMENTAL
Intervention: LSM plus Met
Number of subjects: 502

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 502
Study: 15372382

Group type: EXPERIMENTAL
Intervention: Temperature-controlled radiofrequency (80 degrees C, 60 seconds)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Voltage-controlled radiofrequency (20 V, 60 seconds)
Number of subjects: 33
Study: 11740193

Group type: EXPERIMENTAL
Intervention: Prednisolone (40 mg once daily for the first 2 weeks)
Number of subjects: 229

Group type: COMPARATOR
Intervention: No Prednisolone
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: NVP group
Number of subjects: 229

Group type: COMPARATOR
Intervention: Non-NVP group
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: High baseline CD4 cell count
Number of subjects: 229
Study: 9922474

Group type: EXPERIMENTAL
Intervention: Pamidronate infusions (30 or 45 mg weekly)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Pamidronate infusions (30 or 45 mg every three months or 90 mg every six months)
Number of subjects: 20
Study: 8118635

Group type: EXPERIMENTAL
Intervention: Bronchodilator (BD) treatment
Number of subjects: 169
Study: 2784606

Group type: EXPERIMENTAL
Intervention: Propofol induction
Number of subjects: 152

Group type: COMPARATOR
Intervention: Thiopental induction
Number of subjects: 152
Study: 4890207

Group type: EXPERIMENTAL
Intervention: Prednisolone
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Azathioprine-prednisolone combination
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Azathioprine-prednisolone treatment prolonged to one year
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (Prednisolone)
Number of subjects: 20
Study: 30380584

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Psychodynamic therapy (PDT)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Waiting list (WL)
Number of subjects: 103
Study: 28445097

Group type: EXPERIMENTAL
Intervention: Naldemedine 0.1 mg
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Naldemedine 0.2 mg
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Naldemedine 0.4 mg
Number of subjects: 227

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 227
Study: 25175629

Group type: EXPERIMENTAL
Intervention: Silver alginate dressing
Number of subjects: 500

Group type: COMPARATOR
Intervention: Standard gauze dressing
Number of subjects: 500
Study: 22770506

Group type: EXPERIMENTAL
Intervention: Running
Number of subjects: 44

Group type: COMPARATOR
Intervention: Cycling
Number of subjects: 44

Group type: COMPARATOR
Intervention: Swimming
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control
Number of subjects: 44
Study: 21467231

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (30 minutes, 5 times a week for 16 weeks)
Number of subjects: 391

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 391
Study: 19173833

Group type: EXPERIMENTAL
Intervention: Three-field lymph node dissection (Three-FD)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Two-field lymph node dissection (Two-FD)
Number of subjects: 122
Study: 17702264

Group type: EXPERIMENTAL
Intervention: Eszopiclone 3 mg
Number of subjects: 830
Study: 14977031

Group type: EXPERIMENTAL
Intervention: Asymmetrical body position (head rotated 68 degrees clockwise or counterclockwise)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Symmetrical body position (sitting in a completely symmetrical position)
Number of subjects: 0
Study: 11841126

Group type: EXPERIMENTAL
Intervention: Nucare presented in an individual format
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Nucare presented in a group format
Number of subjects: 225

Group type: COMPARATOR
Intervention: non‐directive supportive group
Number of subjects: 225

Group type: COMPARATOR
Intervention: no‐intervention control
Number of subjects: 225
Study: 9625095

Group type: EXPERIMENTAL
Intervention: Luteolin (279 micromol/L)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Myricetin (279 micromol/L)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quercetin (279 micromol/L)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Kaempferol (279 micromol/L)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quercitrin (279 micromol/L)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Apigenin (279 micromol/L)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quercetin-3-glucoside (279 micromol/L)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rutin (279 micromol/L)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitamin C (279 micromol/L)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quercetin (23.2 micromol/L)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitamin C (23.2 micromol/L)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quercetin and Vitamin C (23.2 micromol/L each)
Number of subjects: 0
Study: 7883394

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training
Number of subjects: 14
Study: 3375957

Group type: EXPERIMENTAL
Intervention: Pleurectomy for diffuse malignant mesothelioma
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Extrapleural pneumonectomy for diffuse malignant mesothelioma
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Surgical treatment for lung cancer in asbestos-exposed patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Surgery for benign pleural plaques
Number of subjects: 0
Study: 30388439

Group type: EXPERIMENTAL
Intervention: Spermidine-rich plant extract supplement
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 27342073

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT): 4×4-min intervals at 85-95% maximum heart rate (HRmax) with a 4-min recovery period at 65% HRmax.
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT): Completing a resistance circuit until an expenditure of 500 kcal at 40-80% of one-rep max (1RM) has been achieved.
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combined Training (HIIT + RT): Combination of both HIIT and RT interventions.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Non-exercise group: usual care with dietary support.
Number of subjects: 60
Study: 24941837

Group type: EXPERIMENTAL
Intervention: Integrated Chinese medical treatment (CM treatment) as maintenance therapy
Number of subjects: 69

Group type: COMPARATOR
Intervention: Western drug chemotherapy (Gemcitabine or Alimta or docetaxel)
Number of subjects: 69
Study: 22619193

Group type: EXPERIMENTAL
Intervention: 1 mL of 4 mg/mL dexamethasone sodium phosphate
Number of subjects: 82

Group type: COMPARATOR
Intervention: 1 mL of normal saline (placebo)
Number of subjects: 82
Study: 20927003

Group type: EXPERIMENTAL
Intervention: Constraint Induced Movement Therapy
Number of subjects: 76
Study: 18256391

Group type: EXPERIMENTAL
Intervention: Thrombus aspiration
Number of subjects: 1071

Group type: COMPARATOR
Intervention: Conventional PCI
Number of subjects: 1071
Study: 16085220

Group type: EXPERIMENTAL
Intervention: Injection of a soluble TNF receptor (TNFR:Fc, etanercept, Enbrel) 25mg subcutaneously, twice weekly for 2 weeks
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 11918622

Group type: EXPERIMENTAL
Intervention: Atorvastatin (hydroxymethylglutaryl coenzyme A reductase inhibitor)
Number of subjects: 2838

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2838
Study: 10400847

Group type: EXPERIMENTAL
Intervention: Mometasone furoate aqueous nasal spray (MFNS) 25 microgram once daily
Number of subjects: 679

Group type: EXPERIMENTAL
Intervention: Mometasone furoate aqueous nasal spray (MFNS) 100 microgram once daily
Number of subjects: 679

Group type: EXPERIMENTAL
Intervention: Mometasone furoate aqueous nasal spray (MFNS) 200 microgram once daily
Number of subjects: 679

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate 84 microgram twice daily (168 microgram/day)
Number of subjects: 679

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 679
Study: 7734238

Group type: EXPERIMENTAL
Intervention: Bipolar hemiarthroplasty
Number of subjects: 32

Group type: COMPARATOR
Intervention: Austin-Moore hemiarthroplasty
Number of subjects: 32
Study: 2139269

Group type: EXPERIMENTAL
Intervention: Closure of the peritoneal layer with continuous catgut
Number of subjects: 0

Group type: COMPARATOR
Intervention: Omission of closure of the peritoneal layer
Number of subjects: 0
Study: 524479

Group type: EXPERIMENTAL
Intervention: Aluminium splint for one week
Number of subjects: 200

Group type: COMPARATOR
Intervention: Plaster of Paris immobilization for three weeks
Number of subjects: 200
Study: 29939060

Group type: EXPERIMENTAL
Intervention: 1-session brief intervention targeting alcohol misuse with personalized feedback and psychoeducation on PTSD symptoms and coping
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Motivational interview accompanying feedback
Number of subjects: 68

Group type: COMPARATOR
Intervention: Feedback only (without motivational interview)
Number of subjects: 68
Study: 28558855

Group type: EXPERIMENTAL
Intervention: High-quality fish oil
Number of subjects: 54

Group type: COMPARATOR
Intervention: Oxidised fish oil
Number of subjects: 54

Group type: COMPARATOR
Intervention: High-oleic sunflower oil (HOSO)
Number of subjects: 54
Study: 26402001

Group type: EXPERIMENTAL
Intervention: Donepezil plus choline alphoscerate
Number of subjects: 113

Group type: COMPARATOR
Intervention: Donepezil alone
Number of subjects: 113
Study: 23668667

Group type: EXPERIMENTAL
Intervention: Web‐Smoke intervention
Number of subjects: 341

Group type: COMPARATOR
Intervention: Web‐Nutrition control
Number of subjects: 341

Group type: COMPARATOR
Intervention: Didactic control
Number of subjects: 341

Group type: COMPARATOR
Intervention: Group control
Number of subjects: 341
Study: 21343698

Group type: EXPERIMENTAL
Intervention: ACWY‐TT (GlaxoSmithKline Biologicals)
Number of subjects: 1025

Group type: COMPARATOR
Intervention: Men‐PS (Mencevax™)
Number of subjects: 1025

Group type: EXPERIMENTAL
Intervention: ACWY‐TT
Number of subjects: 1025

Group type: COMPARATOR
Intervention: ACWY‐TT and Men‐PS
Number of subjects: 1025
Study: 19039596

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BTX‐A) injection
Number of subjects: 30

Group type: COMPARATOR
Intervention: Partial division of puborectalis (PDPR)
Number of subjects: 30
Study: 17503885

Group type: EXPERIMENTAL
Intervention: Trimetazidine 20 mg every 8 hours, starting 15 days before PCI and continuing for 3 months after the procedure.
Number of subjects: 52
Study: 15731325

Group type: EXPERIMENTAL
Intervention: Subarachnoid block with 2.5 mg hyperbaric bupivacaine + 25 mug fentanyl + 1 mL 10% glucose (Group S)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Pudendal nerve block with 7 mL 2% mepivacaine (Group P)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Subarachnoid block (Group S)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Pudendal nerve block (Group P)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 111
Study: 12373268

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP) 1000 microg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP) 100 microg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP) 250 microg
Number of subjects: 32
Study: 9437379

Group type: EXPERIMENTAL
Intervention: Omeprazole
Number of subjects: 100

Group type: COMPARATOR
Intervention: Cimetidine
Number of subjects: 100
Study: 7814237

Group type: EXPERIMENTAL
Intervention: 200 mg vitamin C per day
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study: 2550176

Group type: EXPERIMENTAL
Intervention: nedocromil sodium (2 x 2 mg puffs twice a day)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: nedocromil sodium
Number of subjects: 159

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 159
Study: 368333

Group type: EXPERIMENTAL
Intervention: Clonidine (Dixarit) at a dose of up to 0.15 mg daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0